drugset / Trial / NCT00402025
Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to assess the safety of injections of talimogene laherparepvec into patients with pancreatic cancer that cannot be removed by surgery. The study will also test whether the injections are effective in treating the tumor.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Talimogene Laherparepvec | Other / unclassified | 4 ml | Other |